Steve Galatis is Director, Specialty Asset Strategy at an integrated biopharma company. His current responsibilities cover cardiovascular, fibrosis, immunology, genetically-driven diseases. and virology. He has over 25 years experience in consulting on strategy development and portfolio management in a number of industries, with the last 6 focused exclusively on pharmaceuticals. Steve has a bachelor’s degree in economics from Michigan State and a master’s degree in economics from Stanford. In addition to having given many presentations and workshops on decision quality, strategy development and portfolio management, he has been a guest lecturer for the Boston College Mathematics Department on the topic of mathematical analysis for business decision making.